Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies.
Tarello, W · Comparative immunology, microbiology and infectious diseases · 2001 · DOI
Quick Summary
This study looked at 15 dogs and cats that had fatigue symptoms similar to ME/CFS and tested their blood for bacterial infections. Nine out of 15 animals had a type of bacteria called Staphylococcus in their blood. When these animals were treated with an antibiotic drug, all of them got completely better and the bacteria disappeared from their blood.
Why It Matters
This study raises the possibility that CFS-like conditions might be associated with persistent bacterial infection and bacteremia, which could have implications for understanding potential infectious triggers in human ME/CFS patients. If validated in larger human populations, this could suggest new diagnostic approaches and treatment avenues for a condition where the underlying cause remains unclear.
Observed Findings
9 out of 15 (60%) of animals with CFS-like symptoms tested positive for Staphylococcus species in blood cultures
Micrococci-like organisms were commonly observed in blood smears and correlated with fatigue and pain symptoms
Biochemical abnormalities consistent with myopathy were identified in affected animals
All 15 treated animals experienced complete clinical remission following low-dose arsenical therapy
Microorganisms disappeared from blood within 10-30 days post-treatment, with significant differences from healthy and diseased controls
Inferred Conclusions
Persistent staphylococcal bacteremia may be associated with CFS-like illness in animals
Arsenical therapy may be an effective treatment for CFS-like conditions associated with this bacterial infection
The presence of micrococci in blood may be a biomarker for this form of fatigue illness
Remaining Questions
Does this bacterial infection pattern occur in human ME/CFS patients, and if so, how frequently?
What is the mechanism by which Staphylococcus infection produces CFS-like symptoms and myopathic changes?
What This Study Does Not Prove
This study does not establish that bacterial infection causes ME/CFS in humans—it is limited to 15 animals with only 2 meeting strict CFS diagnostic criteria. The complete remission with arsenical treatment does not prove causation; it demonstrates correlation in this small group and does not necessarily apply to human ME/CFS populations. Additionally, findings in animals do not directly translate to human disease mechanisms without rigorous human validation studies.
Tags
Symptom:PainFatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory OnlyMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →